search
Back to results

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

Primary Purpose

Dysfunctional Labor

Status
Withdrawn
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Propranolol
IV Placebo
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dysfunctional Labor focused on measuring Labor, Dysfunctional Labor, Labor Arrest, Primary Cesarean Section Prevention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Must be term pregnancy (> 37 weeks) Vertex presentation Active labor (4-5 centimeters dilated) Exclusion Criteria: Heart disease Diabetes Currently taking propranolol Contraindications to labor or vaginal delivery Multiple gestations Preterm Chorioamnionitis

Sites / Locations

  • Long Beach Memorial Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

IV Propranolol

IV Placebo

Arm Description

IV dose propranolol

IV Placebo of saline solution equal to propranolol in volume

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
April 17, 2006
Last Updated
February 26, 2019
Sponsor
University of California, Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT00315913
Brief Title
Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor
Official Title
Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Withdrawn
Why Stopped
Lack of feasibility
Study Start Date
January 2004 (undefined)
Primary Completion Date
March 2008 (Actual)
Study Completion Date
March 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.
Detailed Description
This trial was designed to test if propranolo can reduce the c section rate for dysfuctional labor. Due to stringent inclution and exclusion criteria and low enrollment the study was closed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysfunctional Labor
Keywords
Labor, Dysfunctional Labor, Labor Arrest, Primary Cesarean Section Prevention

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IV Propranolol
Arm Type
Experimental
Arm Description
IV dose propranolol
Arm Title
IV Placebo
Arm Type
Placebo Comparator
Arm Description
IV Placebo of saline solution equal to propranolol in volume
Intervention Type
Drug
Intervention Name(s)
Propranolol
Other Intervention Name(s)
Inderal
Intervention Description
IV Propranolol 1mg/min for a total of 2 minutes. Total dose 2mg
Intervention Type
Other
Intervention Name(s)
IV Placebo
Other Intervention Name(s)
Normal Saline
Intervention Description
IV Saline Solution

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Must be term pregnancy (> 37 weeks) Vertex presentation Active labor (4-5 centimeters dilated) Exclusion Criteria: Heart disease Diabetes Currently taking propranolol Contraindications to labor or vaginal delivery Multiple gestations Preterm Chorioamnionitis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leah R Battista, MD
Organizational Affiliation
University of California, Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Long Beach Memorial Medical Center
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

We'll reach out to this number within 24 hrs